Free Trial

IMI (LON:IMI) Earns "Overweight" Rating from JPMorgan Chase & Co.

IMI logo with Industrials background

IMI (LON:IMI - Get Free Report)'s stock had its "overweight" rating restated by equities researchers at JPMorgan Chase & Co. in a research note issued on Wednesday, Marketbeat reports. They presently have a GBX 2,450 ($33.44) price objective on the stock. JPMorgan Chase & Co.'s price objective suggests a potential upside of 16.11% from the company's previous close.

IMI Price Performance

LON IMI traded down GBX 14 ($0.19) on Wednesday, reaching GBX 2,110 ($28.80). 429,258 shares of the company's stock traded hands, compared to its average volume of 1,400,796. IMI has a 12 month low of GBX 1,555.96 ($21.24) and a 12 month high of GBX 2,132 ($29.10). The company has a debt-to-equity ratio of 68.33, a current ratio of 1.36 and a quick ratio of 0.80. The stock has a 50-day simple moving average of GBX 1,972.35 and a 200 day simple moving average of GBX 1,908.89. The stock has a market cap of £5.35 billion, a PE ratio of 21.62, a P/E/G ratio of 1.12 and a beta of 1.08.

Insider Buying and Selling

In other IMI news, insider Jackie Callaway purchased 1,046 shares of IMI stock in a transaction on Tuesday, June 3rd. The shares were acquired at an average cost of GBX 1,971 ($26.90) per share, for a total transaction of £20,616.66 ($28,137.93). Insiders have purchased 1,074 shares of company stock worth $2,117,162 in the last quarter. 1.52% of the stock is owned by company insiders.

IMI Company Profile

(Get Free Report)

IMI plc is a specialist engineering company operating in fluid and motion control markets. We combine our deep engineering knowledge with strong applications expertise to develop solutions for the most acute industry problems. We help our customers become safer, more sustainable and more productive. IMI employs around 10,000 people, has manufacturing facilities in 19 countries and operates a global service network.

Featured Articles

Should You Invest $1,000 in IMI Right Now?

Before you consider IMI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMI wasn't on the list.

While IMI currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines